BIOAF
Price:
$0.0002
Market Cap:
$397.07K
Bioasis Technologies Inc., a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the transport of therapeutic agents across the blood-brain barrier (BBB); and the treatment of central nervous system disorders (CNS), including brain cancers, and metabolic and neurodegenerative diseases. The company's in-house development programs develop symptomatic and disease-modifying treatments for brain metastases (xB3-001), glioblastoma (xB3-002), and neurodegenerative diseases (xB3-007). It has research collaborations with Aposense Limited ...[Read more]
Industry
Biotechnology
IPO Date
2010-12-31
Stock Exchange
OTC
Ticker
BIOAF
According to Bioasis Technologies Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.70. This represents a change of 93.92% compared to the average of 0.36 of the last 4 quarters.
The mean historical Current Ratio of Bioasis Technologies Inc. over the last ten years is 4.25. The current 0.70 Current Ratio has changed 1.56% with respect to the historical average. Over the past ten years (40 quarters), BIOAF's Current Ratio was at its highest in in the August 2014 quarter at 25.39. The Current Ratio was at its lowest in in the May 2020 quarter at 0.09.
Average
4.25
Median
1.35
Minimum
0.26
Maximum
13.48
Discovering the peaks and valleys of Bioasis Technologies Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 512.19%
Maximum Annual Current Ratio = 13.48
Minimum Annual Increase = -75.96%
Minimum Annual Current Ratio = 0.26
| Year | Current Ratio | Change |
|---|---|---|
| 2022 | 0.70 | -56.25% |
| 2021 | 1.61 | 512.19% |
| 2020 | 0.26 | -75.96% |
| 2019 | 1.09 | 8.67% |
| 2018 | 1.01 | 2.96% |
| 2017 | 0.98 | -75.37% |
| 2016 | 3.97 | -52.59% |
| 2015 | 8.38 | -23.68% |
| 2014 | 10.98 | -18.54% |
| 2013 | 13.48 | 93.41% |
The current Current Ratio of Bioasis Technologies Inc. (BIOAF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0.86
5-year avg
0.94
10-year avg
4.25
Bioasis Technologies Inc.’s Current Ratio is greater than IR Biosciences Holdings Inc. (0.01), greater than Easy Technologies Inc. (0.01), greater than Todos Medical Ltd. (0.20), less than enVVeno Medical Corporation (13.12), greater than Regnum Corp. (0.43), greater than GB Sciences, Inc. (0.02), greater than BioLife Sciences Inc. (0.09), greater than GlobeStar Therapeutics Corporation (0), less than Banyan Corp. (0.95), greater than Rimrock Gold Corp. (0),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.01 | $128.12K | |
| 0.01 | $142.22K | |
| 0.20 | $14.08K | |
| 13.12 | $7.86M | |
| 0.43 | $2.29K | |
| 0.02 | $162.83K | |
| 0.09 | $156.68K | |
| 0 | $124.11K | |
| 0.95 | $286.04K | |
| 0 | $156.15K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bioasis Technologies Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bioasis Technologies Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Bioasis Technologies Inc.'s Current Ratio?
How is the Current Ratio calculated for Bioasis Technologies Inc. (BIOAF)?
What is the highest Current Ratio for Bioasis Technologies Inc. (BIOAF)?
What is the 3-year average Current Ratio for Bioasis Technologies Inc. (BIOAF)?
What is the 5-year average Current Ratio for Bioasis Technologies Inc. (BIOAF)?
How does the current Current Ratio for Bioasis Technologies Inc. (BIOAF) compare to its historical average?